[1] 徐蓉蓉,黄文起.右美托咪定药代动力学和药效动力学的研究进展[J].广东医学,2012,33(8):1037-1040.
[2] 杨自娟,张兴安.右美托咪定的临床应用研究[J].中国药物与临床,2013,13(2):189-191.
[3] AKPINAR H,NAZIROGLU M,OVEY I S,et al.The neuroprotective action of dexmedetomidine on apoptosis,calcium entry and oxidative stress in cerebral ischemia-induced rats:contribution of TRPM2 and TRPV1 channels[J].Sci Rep,2016,6:37196.
[4] 王龙梓.右美托咪定神经保护作用及其机制研究进展[J].中国老年学杂志,2016,36(21):5479-5482.
[5] 陶广华,李卫,刘文值.右美托咪定围术期应用的研究进展[J].中国药房,2017,28(5):706-710.
[6] 秦汉,程江霞,赵彬,等.右美托咪定联合浅低温处理对大鼠脑缺血术后认知功能的影响[J].华中科技大学学报(医学版),2014,43(1):76-78,89.
[7] WEERINK M A,STRUYS M M,HANNIVOORT L N,et al.Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine[J].Clin Pharmacokinet,2017,56(8):893-913.
[8] RANGEL R A,MARINHO B G,FERNANDES P D,et al.Pharmacological mechanisms involved in the antinociceptive effects of dexmedetomidine in mice[J].Fundam Clin Pharmacol,2014,28(1):104-113.
[9] ERGENOGLU P,AKIN S,BALI C,et al.Effect of low dose dexmedetomidine premedication on propofol consumption in geriatric end stage renal disease patients[J].Braz J Anesthesiol,2015,65(5):326-332.
[10] MENG Q T,XIA Z Y,LUO T,et al.Dexmedetomidine reduces emergence agitation after tonsillectomy in children by sevoflurane anesthesia:a case-control study[J].Int J Pediatr Otorhinolaryngol,2012,76(7):1036-1041.
[11] 任莉.盐酸右美托咪定在肥胖患者体内的临床药代动力学研究[D].广州:南方医科大学,2014.
[12] CORTINEZ L I,ANDERSON B J,HOLFORD N H,et al.Dexmedetomidine pharmacokinetics in the obese[J].Eur J Clin Pharmacol,2015,71(12):1501-1508.
[13] 周东旭,徐波,屠伟峰,等.右美托咪定在不同肥胖程度患者体内药代动力学研究[J].暨南大学学报(自然科学与医学版),2016,37(3):245-248.
[14] 章冉冉,阳国平,裴奇,等.右美托咪定在特殊人群中的药代动力学研究进展[J].中国临床药理学杂志,2014(7):650-652.
[15] 冯艳,魏芳.小剂量右美托咪定联合丙泊酚在肥胖者无痛人流术中的麻醉效果观察[J].中国实用乡村医生杂志,2016,23(8):62-64.
[16] TUFANOGULLARI B,WHITE P F,PEIXOTO M P,et al.Dexmedetomidine infusion during laparoscopic bariatric surgery:the effect on recovery outcome variables[J].Anesth Analg,2008,106(6):1741-1748.
[17] FILBEY W A,SANFORD D T,BAGHDOYAN H A,et al.Eszopiclone and dexmedetomidine depress ventilation in obese rats with features of metabolic syndrome[J].Sleep,2014,37(5):871-880.
[18] 周冬梅.按照不同体重标准使用右美托咪啶对肥胖患者进行经鼻气管插管麻醉的效果分析[J].当代医药论丛,2015(4):260-261.
[19] 郑丽花,邵雪泉,杨淑芬,等.右美托咪定清醒慢诱导用于肥胖患者气管插管的临床观察[J].浙江临床医学,2014(9):1486-1487.
[20] 杜萍,王春平,刘卫敬,等.右美托咪啶单次负荷剂量给药在肥胖患者椎管内麻醉镇静的临床观察[J].河北医科大学学报,2014,35(1):97-99.
[21] HONG J Y,KIM W O,YOON Y,et al.Effects of intravenous dexmedetomidine on low-dose bupivacaine spinal anaesthesia in elderly patients[J].Acta Anaesthesiol Scand,2012,56(3):382-387.
[22] HEIL L B,SANTOS C L,SANTOS R S,et al.The effects of short-term propofol and dexmedetomidine on lung mechanics,histology,and biological markers in experimental obesity[J].Anesth Analg,2016,122(4):1015-1023.
[23] ERDOGAN KAYHAN G,GUL M,KAYHAN B,et al.Dexmedetomidine ameliorates TNBS-induced colitis by inducing immunomodulator effect[J].J Surg Res,2013,183(2):733-741.
[24] BULOW N M,COLPO E,PEREIRA R P,et al.Dexmedetomidine decreases the inflammatory response to myocardial surgery under mini-cardiopulmonary bypass[J].Braz J Med Biol Res,2016,49(4):e4646.
[25] JIANG L,HU M,LU Y,et al.The protective effects of dexmedetomidine on ischemic brain injury:a meta-analysis[J].J Clin Anesth,2017,40:25-32.
[26] KHAN S A,ALI A,KHAN S A,et al.Unraveling the complex relationship triad between lipids,obesity,and inflammation[J].Mediators Inflamm,2014,5:209-218
[27] HOFER R E,SPRUNG J,SARR M G,et al.Anesthesia for a patient with morbid obesity using dexmedetomidine without narcotics[J].Can J Anesth,2005,52(2):176-180.
[28] RAMSAY M A,SAHA D,HEBELER R F.Tracheal resection in the morbidly obese patient:the role of dexmedetomidine[J].J Clin Anesth,2006,18(6):452-454. |
